Compare MobilEye Global Inc (MBLY) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
MobilEye Global Inc vs Roivant Sciences Ltd. Common Shares — how do they compare? MobilEye Global Inc trades at $7.1 (market cap $6.00B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 4.1× MobilEye Global Inc's market cap, and Roivant Sciences Ltd. Common Shares is trading nearer its 52-week high, MobilEye Global Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold MobilEye Global Inc for 15 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| MBLY | ROIV | |
|---|---|---|
Market Cap | $6.00B | $24.72B |
Volume | 7,007,849 | 6,279,442 |
Sector | Consumer Cyclical | Health |
52-Week High | $15.42 | $41.81 |
52-Week Low | $6.56 | $16.04 |
Typical Hold Time | 15 Days | 1 Days |
Enterprise Value | $4.56B | $20.99B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Mobileye Global (MBLY) trades at $7.06, down 1.26% with bearish technical signals despite recent earnings beats. The company shows strong revenue growth to $1.9B in 2025 but faces significant profitability challenges with a -201.49% net income margin. Analyst consensus leans bullish with a $10.83 price target, while institutional activity shows mixed positioning amid autonomous driving sector volatility.
MBLY presents a high-risk opportunity with substantial upside potential if profitability improves, but current negative margins and bearish technicals suggest caution. The autonomous driving market position remains strong, though execution risks and competitive pressures could limit near-term gains despite Wall Street's optimistic price targets.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About MobilEye Global Inc
Mobileye Global Inc. is a global leader in the development and deployment of Advanced Driver Assistance Systems (ADAS) and autonomous driving technologies. The company specializes in computer vision, machine learning, and data analysis to create sensing, mapping, and driving policy solutions. Mobileye's technology, including its EyeQ system-on-chips and its crowd-sourced mapping platform (REM), is integrated into vehicles worldwide, aiming to improve road safety and enable the future of autonomous mobility.
Read more on MBLY →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
